Lifecore Biomedical, Inc. LFCR

4.20 (0.09) (2.10%) as of 25 Sep
Market cap
$162.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
May '25 May '24 May '23 May '22 May '21 May '20 May '19 May '18 May '17 May '16
P/E ratio
0.00 14.75 0.00 0.00 0.00 0.00 781.10 15.62 35.77 0.00
P/S ratio
1.85 1.39 2.38 2.52 3.38 1.97 0.50 0.74 0.81 0.66
P/FCF ratio
0.00 0.00 0.00 0.00 12.14 0.00 0.00 0.00 49.47 0.00
P/Operating CF
44.74 20.42 (108.47) (510.82) 58.08 (24.89) (196.87) (745.19) 57.36 21.85
P/B ratio
179.05 15.73 0.00 3.09 1.68 1.37 1.04 1.54 1.67 1.47
Price to Tangible BV
0.00 0.00 0.00 3.88 2.38 2.56 1.90 2.20 2.54 2.22
EV/Sales
2.97 2.49 3.80 3.84 5.29 3.16 0.77 0.87 0.92 0.76
EV/EBITDA
0.00 39.86 308.09 6.97 25.57 40.66 15.80 15.63 15.07 0.00
EV/Operating CF
(74.55) (47.08) (18.80) (15.88) 15.28 (15.83) 20.61 17.55 12.17 15.81
EV/FCF
(30.80) (9.26) (8.46) (6.32) 19.00 (7.01) (10.16) (27.38) 55.76 (11.52)
Quick Ratio
1.22 0.91 1.22 0.22 0.42 0.47 0.52 0.64 1.01 1.00
Current Ratio
2.84 2.08 2.39 0.66 1.46 0.96 0.97 1.10 1.58 1.53
Net Debt/EBITDA
(15.59) (158.92) (20.15) 1.74 17.45 32.11 7.14 2.69 1.89 (4.56)
Debt/Assets
63.50% 59.02% 65.69% 53.93% 38.55% 35.16% 28.70% 18.02% 15.05% 17.85%
Debt/Equity
3.20 2.78 4.75 1.69 0.96 0.82 0.55 0.29 0.24 0.29
Asset Turnover
0.52 0.51 0.39 0.29 0.19 0.30 1.21 1.37 1.34 1.38
Operating CF/Net income
0.00 0.02 0.18 0.19 (0.51) 0.45 38.98 0.80 2.82 (1.78)
Capex/Depreciation
(0.80) (2.31) (1.48) (0.30) (0.62) (0.76) (2.92) (2.70) (2.15) (4.21)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(701.27%) 339.11% (238.21%) (80.32%) (14.89%) (15.24%) 0.16% 10.33% 4.81% (5.38%)
ROA
(17.98%) 4.73% (37.70%) (30.02%) (6.19%) (7.20%) 0.09% 6.51% 3.02% (3.38%)
ROIC
(5.64%) (2.83%) (7.46%) (3.14%) (1.39%) (3.84%) 0.82% 2.63% 3.32% (4.89%)
Return on Tangible Assets
(24.04%) 6.28% (52.69%) (198.64%) (19.37%) (20.64%) 0.21% 14.75% 6.50% (7.72%)
Average Days of Receivables
81.26 77.07 102.58 125.68 149.91 173.77 45.54 37.51 35.66 35.52
Research and Development Expense of Revenue
6.41% 6.69% 8.46% 7.05% 6.63% 4.74% 2.06% 2.44% 2.02% 1.52%
Selling, General and Administrative Expense of Revenue
34.18% 31.55% 37.74% 31.15% 27.48% 25.41% 11.13% 9.91% 11.17% 9.68%
Intangible Assets out of Total Assets
0.08 0.07 0.07 0.07 0.12 0.20 0.24 0.19 0.22 0.21
Share Based Compensation of Revenue
7.88% 4.83% 3.50% 2.34% 3.33% 1.51% 0.64% 0.84% 0.84% 0.73%
Graham Net Nets
(0.44) (0.67) (0.51) (0.23) (0.45) (0.48) (0.41) (0.14) (0.13) (0.14)
Graham Number
0.00 1.82 3.19 0.00 0.00 0.00 1.65 13.65 8.58 0.00
Earnings Yield
(16.30%) 6.78% (39.04%) (34.85%) (9.60%) (12.09%) 0.13% 6.40% 2.80% (3.72%)
Free Cash Flow Yield
(5.21%) (19.38%) (18.93%) (24.16%) 8.24% (22.84%) (15.01%) (4.31%) 2.02% (10.10%)
Revenue per Share
3.70 4.21 3.45 3.78 3.44 5.49 19.66 19.04 17.22 17.63
Operating CF per Share
(0.01) 0.01 (0.58) (0.77) 0.56 (0.58) 0.56 0.72 1.09 0.77
Capex per Share
(0.18) (0.60) (0.72) (0.98) (0.42) (0.83) (1.57) (1.22) (0.84) (1.46)
Free Cash Flow per Share
(0.19) (0.60) (1.30) (1.74) 0.14 (1.42) (1.00) (0.50) 0.25 (0.70)
Cash per Share
0.24 0.28 0.64 0.03 0.04 0.01 0.04 0.11 0.22 0.37
Shareholders Equity per Share
1.36 1.77 1.17 2.98 6.92 7.92 9.53 9.17 8.36 7.85
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.36 1.77 1.17 2.98 6.92 7.92 9.53 9.17 8.36 7.85
Free Cash Flow
(6.62) (18.14) (38.92) (51.39) 4.16 (41.29) (28.45) (13.71) 6.92 (18.81)
Working Capital
55.50 42.16 54.59 (59.91) 46.43 (7.28) (4.05) 8.69 29.83 29.96
Capital Expenditures
(6.41) (18.39) (21.48) (28.80) (12.31) (24.25) (44.47) (33.49) (22.92) (39.57)
Net Current Asset Value
(106.23) (119.02) (124.58) (70.21) (151.82) (153.16) (115.91) (55.08) (49.18) (44.00)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 78.40 33.73 29.34 0.00
Capex to Sales
0.05 0.14 0.21 0.26 0.12 0.15 0.08 0.06 0.05 0.08
Net Profit Margin
(34.42%) 9.37% (96.41%) (104.89%) (32.01%) (23.86%) 0.07% 4.74% 2.25% (2.44%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 51.38 28.57 26.03 0.00
Other line items
Depreciation/Fixed assets
0.06 0.05 0.11 0.81 0.17 0.17 0.08 0.08 0.08 0.08
Cash ROIC
(62.21%) (70.15%) (68.79%) (59.61%) (26.09%) (49.65%) (43.79%) (42.58%) (35.88%) (35.33%)
Accounts Receivable Turnover
4.62 4.57 3.07 2.79 1.72 2.20 9.03 10.51 10.18 10.27
Accounts Payable Turnover
7.21 4.50 4.30 4.94 1.82 2.29 10.75 15.07 14.09 12.44
Inventory Turnover
2.45 2.14 1.96 1.46 0.96 2.00 11.09 16.09 15.89 16.22
Average Days of Payables
33.88 68.99 107.13 65.47 96.05 156.21 41.34 28.38 22.92 27.50
Days of Inventory on Hand
133.07 168.87 198.01 181.98 371.71 200.56 41.46 26.05 22.07 22.72
Average Receivables
27.89 28.05 33.67 39.87 58.82 72.89 61.72 49.89 46.15 46.44
Average Payables
12.28 19.22 17.52 14.63 33.97 52.81 44.32 29.60 27.72 32.96
Average Inventory
36.14 40.41 38.42 49.54 64.69 60.22 42.98 27.72 24.58 25.28
Average Assets
246.65 253.75 264.12 388.81 522.12 530.20 461.90 381.66 350.63 344.56
Average Common Equity
6.33 3.54 41.80 145.30 216.91 250.59 261.35 240.36 220.25 216.23

Fold the line items

Columns are period end dates